SK

Sunil Kumar Gupta

Active Director Director DIN 09670475
DIN 09670475 First appointment Jul 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Sunil Kumar Gupta

Data last updated:

Sunil Kumar Gupta is a Director at K3 Pharma Private Limited (since 2022). The company operates in Chemicals. K3 Pharma Private Limited reported revenue of ₹4.2 Lakh (FY 2024).

DIN 09670475
Primary Designation Director
Industry Chemicals
First Appointment 12 Jul 2022
Oldest Company Age 4 yrs
Largest company K3 Pharma Private Limited · ₹4.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
K3 Pharma Private Limited U24230UP2022PTC167434
Director12 Jul 20222022₹4.2 Lakh (FY 2024)Active

Board colleagues of Sunil Kumar Gupta

NameDINCompanyDesignation
Anjily Satyam09670476K3 Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
K3 Pharma Private Limited
Premium access

Shareholding and investment profile for Sunil Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Kumar Gupta

Sunil Kumar Gupta currently holds 1 directorship: K3 Pharma Private Limited (Director, since 12 Jul 2022, revenue ₹4.2 Lakh (FY 2024)).

Sunil Kumar Gupta was first appointed on 12 Jul 2022 as Director at K3 Pharma Private Limited.

The current boards of Sunil Kumar Gupta's companies include Anjily Satyam (K3 Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available